Sophia Randolph compensation by year
ALX ONCOLOGY Summary Compensation Table · all 6 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Salary | $351,100 | $397,588 | $453,200 | $471,330 | $510,000 | $468,922 |
| Bonus | $0 | $350,000 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $424,390 | $199,240 | $1,425,600 |
| Option awards | $40,834 | $1,818,862 | $4,116,990 | $1,022,942 | $461,652 | $1,131,736 |
| Non-equity incentive | $105,400 | $190,915 | $181,280 | $165,908 | $204,000 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $0 | $0 | $503,880 |
| Total | $497,334 | $2,757,365 | $4,751,470 | $2,084,570 | $1,374,892 | $3,530,138 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ALX ONCOLOGY HOLDINGS INC DEF 14A filed April 21, 2025, accession 0000950170-25-056291, and prior-year filings.
How this page was built: the ALX ONCOLOGY HOLDINGS INC filed document, accession 0000950170-25-056291. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2025.
ALX ONCOLOGY’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Jason Lettmann | Chief Executive Officer | $6,640,830 |
| Sophia Randolph · this page | Former Chief Medical Officer | $3,530,138 |
| Jaume Pons | Former President and Chief Scientific Officer | $3,017,955 |
| Peter Garcia | Former Chief Financial Officer | $2,697,079 |
| Shelly Pinto | Senior Vice President, Finance and Chief Accounting Officer | $1,505,161 |
| Shelly Wong | Senior Vice President, Finance and Chief Accounting Officer | $1,505,161 |
Board service
ALX ONCOLOGY board · FY2023How this board is paid
Company policy: ALX ONCOLOGY pays directors a $40,000 cash retainer. As stated in ALX ONCOLOGY's FY2023 proxy.
The full ALX ONCOLOGY compensation record
free company briefThis page is one person within ALX ONCOLOGY's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the ALX ONCOLOGY proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ALX ONCOLOGY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.